Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- VIM0423Phase 22 trials
Vima Therapeutics · PARKINSON DISEASE (Disorder), Dystonia
- VIS954Phase 22 trials
Otsuka · Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Inflammatory Skin Diseases
- VNX001Phase 22 trials
Vaneltix Pharma, Inc. · Interstitial Cystitis, Bladder Pain Syndrome
- VolixibatSHP626Phase 22 trials
Mirum Pharmaceuticals, Inc. · Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, PBC
- VortosiranPhase 22 trials
Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)
- VTX3232Phase 22 trials
Zomagen Biosciences Ltd. · Idiopathic Parkinson Disease, Obesity
- vudalimabPhase 22 trials
Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer
- VutiglabridinHSG4112Phase 22 trials
Glaceum · Knee Osteoarthritis (Knee OA), Parkinson Disease
- VX-670Phase 22 trials
Vertex Pharmaceuticals · Myotonic Dystrophy Type 1 (DM1)
- VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- WGI-0301Phase 22 trials
Zhejiang Haichang Biotech Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC), Hepato Cellular Carcinoma (HCC), Renal Cell Cancer
- WIN378Phase 22 trials
Windward Bio · COPD (Chronic Obstructive Pulmonary Disease), Asthma
- WJB001Phase 22 trials
Wigen Biomedicine Technology (Shanghai) Co., Ltd. · Advanced Solid Tumor, Advanced Solid Tumors
- WVE-N531Phase 22 trials
Wave Life Sciences USA, Inc. · Duchenne Muscular Dystrophy
- XH-S003Phase 22 trials
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · PNH - Paroxysmal Nocturnal Hemoglobinuria, IgA Nephropathy
- XKH001InjectionXKH001Phase 22 trials
Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis
- XNW27011ASP546CPhase 22 trials
Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
- YK012Phase 22 trials
Excyte Biopharma Ltd · Systemic Lupus Erythematosus (SLE), B-cell Acute Lymphoblastic Leukemia
- YL202 should be intravenously infusedPhase 22 trials
MediLink Therapeutics (Suzhou) Co., Ltd. · NSCLC, Breast Cancer, HNSCC
- YN001Phase 22 trials
Beijing Inno Medicine Co., Ltd. · Atherosclerosis, Coronary Artery Disease, Atherosclerotic Cardiovascular Disease
- ZalifrelimabPhase 22 trials
ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer
- ZelquistinelGATE-251Phase 22 trials
Syndeio Biosciences, Inc · Major Depressive Disorder
- ZEN003694ZEN-3694Phase 22 trials
Zenith Epigenetics · mCRPC, Metastatic Castration-Resistant Prostate Cancer
- ZGGS18Phase 22 trials
Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Advanced Solid Tumor
- A group Purinostat MesylatePhase 21 trial
Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor
- A195Phase 21 trial
XyloCor Therapeutics, Inc. · Coronary Artery Disease (CAD)
- AAVB-039Phase 21 trial
AAVantgarde Bio Srl · Stargardt Disease
- AAVB-081Phase 21 trial
AAVantgarde Bio Srl · Usher Syndrome, Type 1B
- AB-2100Integrated Circuit T cellsPhase 21 trial
Arsenal Biosciences, Inc. · Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence
- AB-729Phase 21 trial
Arbutus Biopharma Corporation · Chronic Hepatitis b
- AB680Phase 21 trial
Arcus Biosciences, Inc. · Metastatic Colorectal Cancer
- AB8939Phase 21 trial
AB Science · Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia
- ABBV-142Phase 21 trial
AbbVie · Idiopathic Pulmonary Fibrosis
- ABBV-1758Phase 21 trial
AbbVie · Alzheimer's Disease
- ABBV-2001Phase 21 trial
AbbVie · Multiple Myeloma
- ABBV-547Phase 21 trial
AbbVie · Psoriatic Arthritis
- ABBV-6628Phase 21 trial
AbbVie · Geographic Atrophy, Age-Related Macular Degeneration
- ABBV-668Phase 21 trial
AbbVie · Ulcerative Colitis
- ABBV-8736Phase 21 trial
AbbVie · Crohn's Disease
- ABBV-916Phase 21 trial
AbbVie · Alzheimer's Disease (AD)
- ABCL635Phase 21 trial
AbCellera Biologics Inc. · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
- ABD-3001DIMATEPhase 21 trial
Advanced BioDesign · Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes
- ABI-110Phase 21 trial
Avirmax Biopharma Inc · Neovascular (Wet) AMD
- ABI-2280Phase 21 trial
Antiva Biosciences · Human Papillomavirus Infection
- ABI-6250Phase 21 trial
Assembly Biosciences · Chronic Hepatitis D Infection
- ABL103Phase 21 trial
ABL Bio, Inc. · Solid Tumors
- ABO-101Phase 21 trial
Arbor Biotechnologies · Primary Hyperoxaluria Type 1 (PH1)
- ABO1105Phase 21 trial
Suzhou Abogen Biosciences Co., Ltd. · Respiratory Syncytial Virus
- ABO2011ABOD2011Phase 21 trial
Suzhou Abogen Biosciences Co., Ltd. · Solid Tumor, Adult
- ABP1011TPhase 21 trial
Shanghai AB PharmaTech Ltd. · SCLC, Extensive Stage, Advanced Solid Tumors
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.